227 related articles for article (PubMed ID: 26142707)
1. Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.
Pulvino M; Chen L; Oleksyn D; Li J; Compitello G; Rossi R; Spence S; Balakrishnan V; Jordan C; Poligone B; Casulo C; Burack R; Shapiro JL; Bernstein S; Friedberg JW; Deshaies RJ; Land H; Zhao J
Oncotarget; 2015 Jun; 6(17):14796-813. PubMed ID: 26142707
[TBL] [Abstract][Full Text] [Related]
2. COP9 signalosome subunit Csn8 is involved in maintaining proper duration of the G1 phase.
Liu C; Guo LQ; Menon S; Jin D; Pick E; Wang X; Deng XW; Wei N
J Biol Chem; 2013 Jul; 288(28):20443-52. PubMed ID: 23689509
[TBL] [Abstract][Full Text] [Related]
3. MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma.
Shi JQ; Lasky K; Shinde V; Stringer B; Qian MG; Liao D; Liu R; Driscoll D; Nestor MT; Amidon BS; Rao Y; Duffey MO; Manfredi MG; Vos TJ; D' Amore N; Hyer ML
Mol Cancer Ther; 2012 Sep; 11(9):2045-53. PubMed ID: 22609854
[TBL] [Abstract][Full Text] [Related]
4. AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation.
Tsai HJ; Shih NY; Kuo SH; Cheng AL; Lin HY; Chen TY; Chang KC; Lin SF; Chang JS; Chen LT
Leuk Lymphoma; 2015; 56(9):2674-82. PubMed ID: 25535814
[TBL] [Abstract][Full Text] [Related]
5. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma.
Yang Y; Shaffer AL; Emre NC; Ceribelli M; Zhang M; Wright G; Xiao W; Powell J; Platig J; Kohlhammer H; Young RM; Zhao H; Yang Y; Xu W; Buggy JJ; Balasubramanian S; Mathews LA; Shinn P; Guha R; Ferrer M; Thomas C; Waldmann TA; Staudt LM
Cancer Cell; 2012 Jun; 21(6):723-37. PubMed ID: 22698399
[TBL] [Abstract][Full Text] [Related]
6. Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.
Hao Y; Chapuy B; Monti S; Sun HH; Rodig SJ; Shipp MA
Clin Cancer Res; 2014 May; 20(10):2674-83. PubMed ID: 24610827
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.
Pearce C; Hayden RE; Bunce CM; Khanim FL
BMC Cell Biol; 2009 Apr; 10():31. PubMed ID: 19400951
[TBL] [Abstract][Full Text] [Related]
8. Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects.
Bentayeb H; Aitamer M; Petit B; Dubanet L; Elderwish S; Désaubry L; de Gramont A; Raymond E; Olivrie A; Abraham J; Jauberteau MO; Troutaud D
J Exp Clin Cancer Res; 2019 Nov; 38(1):450. PubMed ID: 31684984
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of the COP9 signalosome for treatment of cancer.
Schlierf A; Altmann E; Quancard J; Jefferson AB; Assenberg R; Renatus M; Jones M; Hassiepen U; Schaefer M; Kiffe M; Weiss A; Wiesmann C; Sedrani R; Eder J; Martoglio B
Nat Commun; 2016 Oct; 7():13166. PubMed ID: 27774986
[TBL] [Abstract][Full Text] [Related]
10. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
Adler AS; Littlepage LE; Lin M; Kawahara TL; Wong DJ; Werb Z; Chang HY
Cancer Res; 2008 Jan; 68(2):506-15. PubMed ID: 18199546
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma.
Hashiguchi T; Bruss N; Best S; Lam V; Danilova O; Paiva CJ; Wolf J; Gilbert EW; Okada CY; Kaur P; Drew L; Cidado J; Hurlin P; Danilov AV
Mol Cancer Ther; 2019 Sep; 18(9):1520-1532. PubMed ID: 31243099
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
[TBL] [Abstract][Full Text] [Related]
13. Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma.
Pore D; Bodo J; Danda A; Yan D; Phillips JG; Lindner D; Hill BT; Smith MR; Hsi ED; Gupta N
Leukemia; 2015 Sep; 29(9):1857-67. PubMed ID: 25801911
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A.
Pulvino M; Liang Y; Oleksyn D; DeRan M; Van Pelt E; Shapiro J; Sanz I; Chen L; Zhao J
Blood; 2012 Aug; 120(8):1668-77. PubMed ID: 22791293
[TBL] [Abstract][Full Text] [Related]
15. Electron microscopy and in vitro deneddylation reveal similar architectures and biochemistry of isolated human and Flag-mouse COP9 signalosome complexes.
Rockel B; Schmaler T; Huang X; Dubiel W
Biochem Biophys Res Commun; 2014 Jul; 450(2):991-7. PubMed ID: 24973710
[TBL] [Abstract][Full Text] [Related]
16. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway.
Ray DM; Morse KM; Hilchey SP; Garcia TM; Felgar RE; Maggirwar SB; Phipps RP; Bernstein SH
Exp Hematol; 2006 Sep; 34(9):1202-11. PubMed ID: 16939813
[TBL] [Abstract][Full Text] [Related]
17. The COP9 signalosome is involved in the regulation of lipid metabolism and of transition metals uptake in Saccharomyces cerevisiae.
Licursi V; Salvi C; De Cesare V; Rinaldi T; Mattei B; Fabbri C; Serino G; Bramasole L; Zimbler JZ; Pick E; Barnes BM; Bard M; Negri R
FEBS J; 2014 Jan; 281(1):175-90. PubMed ID: 24164706
[TBL] [Abstract][Full Text] [Related]
18. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.
Panattoni M; Sanvito F; Basso V; Doglioni C; Casorati G; Montini E; Bender JR; Mondino A; Pardi R
J Exp Med; 2008 Feb; 205(2):465-77. PubMed ID: 18268034
[TBL] [Abstract][Full Text] [Related]
19. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
[TBL] [Abstract][Full Text] [Related]
20. Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.
Aoki T; Shimada K; Sakamoto A; Sugimoto K; Morishita T; Kojima Y; Shimada S; Kato S; Iriyama C; Kuno S; Harada Y; Tomita A; Hayakawa F; Kiyoi H
Oncotarget; 2017 Feb; 8(8):13085-13098. PubMed ID: 28055963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
